Related Experiment Video
Updated: Oct 22, 2025

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
Multidrug-Resistant Klebsiella pneumoniae Causing Severe Infections in the Neuro-ICU
Nadezhda K Fursova1, Evgenii I Astashkin1, Olga N Ershova2
1Department of Molecular Microbiology, State Research Center for Applied Microbiology and Biotechnology, Territory "Kvartal A", 142279 Obolensk, Russia.
Abstract:
The purpose of this study was the identification of genetic lineages and antimicrobial resistance (AMR) and virulence genes in Klebsiella pneumoniae isolates associated with severe infections in the neuro-ICU. Susceptibility to antimicrobials was determined using the Vitek-2 instrument. AMR and virulence genes, sequence types (STs), and capsular types were identified by PCR. Whole-genome sequencing was conducted on the Illumina MiSeq platform. It was shown that K. pneumoniae isolates of ST14K2, ST23K57, ST39K23, ST76K23, ST86K2, ST218K57, ST219KL125/114, ST268K20, and ST2674K47 caused severe systemic infections, including ST14K2, ST39K23, and ST268K20 that were associated with fatal incomes. Moreover, eight isolates of ST395K2 and ST307KL102/149/155 were associated with manifestations of vasculitis and microcirculation disorders. Another 12 K. pneumoniae isolates of ST395K2,KL39, ST307KL102/149/155, and ST147K14/64 were collected from patients without severe systemic infections. Major isolates (n = 38) were XDR and MDR. Beta-lactamase genes were identified: blaSHV (n = 41), blaCTX-M (n = 28), blaTEM (n = 21), blaOXA-48 (n = 21), blaNDM (n = 1), and blaKPC (n = 1). The prevalent virulence genes were wabG (n = 41), fimH (n = 41), allS (n = 41), and uge (n = 34), and rarer, detected only in the genomes of the isolates causing severe systemic infections-rmpA (n = 8), kfu (n = 6), iroN (n = 5), and iroD (n = 5) indicating high potential of the isolates for hypervirulence.
Insights
This study identified specific genetic lineages of Klebsiella pneumoniae causing severe neuro-ICU infections. Certain sequence types (STs) were linked to fatal outcomes and vasculitis, highlighting their hypervirulence and antimicrobial resistance.
Area of Science:
- Medical Microbiology
- Genomics
- Infectious Diseases
Background:
- Klebsiella pneumoniae is a significant cause of hospital-acquired infections.
- Severe infections in neuro-ICU patients require understanding of pathogen genetics and resistance.
- Antimicrobial resistance (AMR) and virulence factors are key determinants of K. pneumoniae pathogenicity.
Purpose of the Study:
- To identify genetic lineages of K. pneumoniae associated with severe neuro-ICU infections.
- To characterize antimicrobial resistance and virulence genes in these isolates.
- To correlate specific sequence types (STs) and capsular types with infection severity and outcomes.
Main Methods:
- Antimicrobial susceptibility testing using Vitek-2.
- Polymerase Chain Reaction (PCR) for AMR and virulence genes, sequence types (STs), and capsular types.
- Whole-genome sequencing (WGS) on the Illumina MiSeq platform.
Main Results:
- Specific STs (e.g., ST14K2, ST39K23, ST268K20) were linked to severe, fatal infections and vasculitis.
- Most isolates (n=38) were extensively drug-resistant (XDR) or multidrug-resistant (MDR).
- Prevalent AMR genes included blaSHV, blaCTX-M, blaTEM, and blaOXA-48. Rare hypervirulence genes (rmpA, kfu, iroN) were found in severe infection isolates.
Conclusions:
- Specific K. pneumoniae STs possess a high potential for hypervirulence and cause severe systemic infections in neuro-ICU settings.
- The presence of XDR/MDR strains with specific virulence factors poses a significant clinical challenge.
- Understanding these genetic determinants is crucial for developing targeted treatment and control strategies.
More Related Videos
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
08:27Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat
Published on: October 29, 2014
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Urinary Tract Infection II: Pathophysiology
Acute Pyelonephritis I: Introduction
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Urinary Tract Infection IV: Nursing Management